Allergist-Immunologist. Co-founder, Alpha Allergy & Asthma Associates. Former Associate Clinical Director of the Johns Hopkins Allergy & Clinical Immunology Division.
Selected to Super Doctors ® Rising Stars ℠ 2013.
Education and Post-graduate Training:
- Doctor of Medicine, Drexel University College of Medicine
- Master of Public Health (MPH), Concentration: Epidemiology and Biostatistics, MCP Hahnemann University School of Public Health
- Johns Hopkins Bayview Medical Center, Internal Medicine Residency
- National Jewish Health & University of Colorado Hospital, Allergy & Immunology Fellowship
- Board Certified in Internal Medicine, American Board of Internal Medicine (ABIM)
- Board Certified in Allergy & Immunology, American Board of Allergy and Immunology (ABAI)
- Selected to the Super Doctors® Rising Stars ℠ 2013 published in The Washington Post
Nkiruka Erekosima, MD MPH (In her own words):
“As a physician, my compelling interest in immunology led me to specialize in Allergy and Immunology – a field of medicine that focuses on the diagnosis, treatment, and management of allergies, asthma, and other disorders of the immune system.
After completing my residency at Johns Hopkins Bayview Medical Center, I was blessed with the opportunity to have my Allergy and Immunology training at National Jewish Health in Denver, Colorado – the leading respiratory hospital in the US, where I provided care for patients from all over the US and the world.
I later returned to Maryland to join the faculty of The Johns Hopkins University School of Medicine, as an Assistant Professor in the Division of Allergy and Clinical Immunology, where I also served as the Associate Clinical Director.
For most of my years as a physician, I practiced in an academic setting where I had several responsibilities including providing care for children and adults, conducting research, and teaching medical students, residents, and clinical fellows.
Over these years, what I have enjoyed and appreciated the most is the personal interactions with my patients and their families, as well as having the opportunity to work together with each patient to achieve his/her treatment goals. I decided to move to a community practice setting to focus primarily on providing patient care while bringing my expertise to my patients. Having grown up in the Washington DC metro area, I wanted to return to this area to serve this community.
My co-founder and I met while working at the Johns Hopkins Asthma and Allergy Center in the Division of Allergy and Clinical Immunology. We both had the privilege and unique experience of caring for patients who were referred to an academic/tertiary care center, where we had access to a broader range of services than that provided at most community allergy clinics.
We indeed shared a similar vision whereby we wanted to bring the expertise and resources available in an academic medical center to the community practice setting. We decided to pursue this vision together. We discovered that there was a need in the North Montgomery County / Silver Spring area for the type of medical clinic that we envisioned and set out to create it.
We have now established an allergy clinic in Silver Spring, MD that serves patients of all ages (children and adults), and is open 5 days a week. We participate in most insurance plans including medicaid and medicare. We are here to serve you, and are committed to providing the best care to you and your family.”
Organizations and Memberships
- American Academy of Allergy Asthma and Immunology
- American College of Allergy Asthma and Immunology
- Joint Council of Allergy Asthma and Immunology
- Maryland Asthma & Allergy Society
- Montgomery County Medical Society
- MedChi, The Maryland State Medical Society
Lin SY, Erekosima N, Kim JM, Ramanathan M, Suarez-Cuervo C, Chelladurai Y, Ward K, Segal JB. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA. 2013; 309:1278-88. PMID: 23532243
Lin SY, Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Ward D, Chelladurai Y, Segal JB. Allergen-specific immunotherapy for the treatment of allergic rhinoconjunctivitis and/or asthma: Comparative Effectiveness Review. Comparative Effectiveness Review No. 111. (Prepared by the Johns Hopkins University Evidence-based Practice Center under Contract No. 290-2007-10061-I.) AHRQ Publication No. 13-EHC061-EF. Rockville, MD: Agency for Healthcare Research and Quality. March 2013. www.effectivehealthcare.ahrq.gov/reports/final.cfm. PMID: 23638484
Kim JM, Lin S, Suarez-Cuervo C, Chelladurai Y, Ramanathan M, Segal J, Erekosima N. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics. 2013; 131:1155-67. PMID: 23650298
Chelladurai Y, Suarez-Cuervo C, Erekosima N, Kim JM, Ramanathan M, Segal JB, Lin SY. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAllergy Clin Immunol: In Practice. 2013. doi: 10.1016/j.jaip.2013.04.005
Erekosima N, Suarez-Cuervo C, Ramanathan M, Kim JM, Chelladurai Y, Segal JB, Lin SY. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: A systematic review.
Laryngoscope. 2013. doi: 10.1002/lary.24295. [Epub ahead of print] PMID: 23832632
Erekosima N, Saini SS. Immediate hypersensitivity: approach to diagnosis. In: Adelman DC, Casale TB, Corren J, eds. Manual of allergy and immunology. Philadelphia, PA: Lippincott, Williams & Wilkins, 2012.
Erekosima N, Katial RK. Assessing nasal symptom control. Current Allergy Asthma Rep. 2009;9:134-139.